annual cash & cash equivalents:
$179.89M+$86.96M(+93.57%)Summary
- As of today (June 23, 2025), TGTX annual cash & cash equivalents is $179.89 million, with the most recent change of +$86.96 million (+93.57%) on December 31, 2024.
- During the last 3 years, TGTX annual cash & cash equivalents has fallen by -$118.99 million (-39.81%).
- TGTX annual cash & cash equivalents is now -67.50% below its all-time high of $553.44 million, reached on December 31, 2020.
Performance
TGTX Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$132.14M-$47.76M(-26.55%)Summary
- As of today (June 23, 2025), TGTX quarterly cash & cash equivalents is $132.14 million, with the most recent change of -$47.76 million (-26.55%) on March 1, 2025.
- Over the past year, TGTX quarterly cash & cash equivalents has increased by +$56.66 million (+75.07%).
- TGTX quarterly cash & cash equivalents is now -76.12% below its all-time high of $553.44 million, reached on December 31, 2020.
Performance
TGTX quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
TGTX Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +93.6% | +75.1% |
| 3 y3 years | -39.8% | -28.8% |
| 5 y5 years | +59.7% | +153.9% |
TGTX Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -39.8% | +93.6% | -32.5% | +115.0% |
| 5 y | 5-year | -67.5% | +93.6% | -76.1% | +153.9% |
| alltime | all time | -67.5% | >+9999.0% | -76.1% | >+9999.0% |
TGTX Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $132.14M(-26.5%) |
| Dec 2024 | $179.89M(+93.6%) | $179.89M(-8.1%) |
| Sep 2024 | - | $195.82M(+136.2%) |
| Jun 2024 | - | $82.91M(+9.8%) |
| Mar 2024 | - | $75.48M(-18.8%) |
| Dec 2023 | $92.93M(-9.2%) | $92.93M(-38.4%) |
| Sep 2023 | - | $150.90M(+55.6%) |
| Jun 2023 | - | $97.01M(+57.8%) |
| Mar 2023 | - | $61.47M(-39.9%) |
| Dec 2022 | $102.30M(-65.8%) | $102.30M(-6.9%) |
| Sep 2022 | - | $109.86M(-25.3%) |
| Jun 2022 | - | $147.07M(-20.8%) |
| Mar 2022 | - | $185.68M(-37.9%) |
| Dec 2021 | $298.89M(-46.0%) | $298.89M(-8.5%) |
| Sep 2021 | - | $326.51M(-18.7%) |
| Jun 2021 | - | $401.71M(-14.8%) |
| Mar 2021 | - | $471.51M(-14.8%) |
| Dec 2020 | $553.44M(+391.3%) | $553.44M(+117.8%) |
| Sep 2020 | - | $254.15M(-2.4%) |
| Jun 2020 | - | $260.51M(+400.5%) |
| Mar 2020 | - | $52.05M(-53.8%) |
| Dec 2019 | $112.64M(+168.5%) | $112.64M(+152.1%) |
| Sep 2019 | - | $44.67M(-21.9%) |
| Jun 2019 | - | $57.23M(-11.1%) |
| Mar 2019 | - | $64.35M(+53.4%) |
| Dec 2018 | $41.96M(-26.0%) | $41.96M(-40.7%) |
| Sep 2018 | - | $70.72M(-33.1%) |
| Jun 2018 | - | $105.67M(+27.5%) |
| Mar 2018 | - | $82.90M(+46.2%) |
| Dec 2017 | $56.72M(+126.6%) | $56.72M(-38.2%) |
| Sep 2017 | - | $91.84M(+18.3%) |
| Jun 2017 | - | $77.60M(-18.9%) |
| Mar 2017 | - | $95.64M(+282.1%) |
| Dec 2016 | $25.03M(-54.5%) | $25.03M(-14.1%) |
| Sep 2016 | - | $29.16M(+2.0%) |
| Jun 2016 | - | $28.58M(-21.7%) |
| Mar 2016 | - | $36.48M(-33.7%) |
| Dec 2015 | $55.06M(-1.2%) | $55.06M(-15.9%) |
| Sep 2015 | - | $65.46M(+8.6%) |
| Jun 2015 | - | $60.30M(-29.9%) |
| Mar 2015 | - | $86.00M(+54.4%) |
| Dec 2014 | $55.71M(+37.6%) | $55.71M(+4.7%) |
| Sep 2014 | - | $53.23M(+43.6%) |
| Jun 2014 | - | $37.08M(-25.2%) |
| Mar 2014 | - | $49.60M(+22.5%) |
| Dec 2013 | $40.49M(+146.0%) | $40.49M(-19.3%) |
| Sep 2013 | - | $50.18M(+274.0%) |
| Jun 2013 | - | $13.42M(-11.7%) |
| Mar 2013 | - | $15.19M(-7.7%) |
| Dec 2012 | $16.46M(+68.8%) | $16.46M(-5.3%) |
| Sep 2012 | - | $17.37M(-14.7%) |
| Jun 2012 | - | $20.37M(-2.7%) |
| Mar 2012 | - | $20.92M(+114.6%) |
| Dec 2011 | $9.75M(+1936.5%) | $9.75M(+4491.9%) |
| Sep 2011 | - | $212.30K(-56.9%) |
| Jun 2011 | - | $492.50K(-16.7%) |
| Mar 2011 | - | $591.30K(+23.5%) |
| Dec 2010 | $478.70K | $478.70K(-55.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2010 | - | $1.08M(-31.6%) |
| Jun 2010 | - | $1.57M(-22.1%) |
| Mar 2010 | - | $2.02M(>+9900.0%) |
| Dec 2009 | $18.00K(-83.0%) | $18.00K(-88.3%) |
| Sep 2009 | - | $153.60K(-47.9%) |
| Jun 2009 | - | $294.60K(+27.8%) |
| Mar 2009 | - | $230.50K(+117.5%) |
| Dec 2008 | $106.00K(-83.7%) | $106.00K(+196.9%) |
| Sep 2008 | - | $35.70K(-93.8%) |
| Jun 2008 | - | $576.40K(-49.1%) |
| Mar 2008 | - | $1.13M(+74.4%) |
| Dec 2007 | $649.70K(-78.6%) | $649.70K(-68.0%) |
| Sep 2007 | - | $2.03M(-57.6%) |
| Jun 2007 | - | $4.79M(-44.9%) |
| Mar 2007 | - | $8.69M(+186.9%) |
| Dec 2006 | $3.03M(-69.2%) | $3.03M(-22.6%) |
| Sep 2006 | - | $3.91M(-35.3%) |
| Jun 2006 | - | $6.05M(-29.1%) |
| Mar 2006 | - | $8.53M(-13.2%) |
| Dec 2005 | $9.83M(+984.9%) | $9.83M(-17.2%) |
| Sep 2005 | - | $11.87M(+1233.7%) |
| Jun 2005 | - | $889.90K(+63.3%) |
| Mar 2005 | - | $545.00K(-39.8%) |
| Dec 2004 | $905.70K(-87.8%) | $905.70K(-87.8%) |
| Sep 2004 | - | $7.41M(-16.4%) |
| Jun 2004 | - | $8.87M(-7.1%) |
| Mar 2004 | - | $9.54M(+28.7%) |
| Dec 2003 | $7.41M(+330.8%) | $7.41M(+7161.3%) |
| Sep 2003 | - | $102.10K(-78.6%) |
| Jun 2003 | - | $477.90K(-58.3%) |
| Mar 2003 | - | $1.15M(-33.4%) |
| Dec 2002 | $1.72M(+8.1%) | $1.72M(+358.0%) |
| Sep 2002 | - | $375.80K(-15.6%) |
| Jun 2002 | - | $445.40K(-52.3%) |
| Mar 2002 | - | $933.20K(-41.4%) |
| Dec 2001 | $1.59M(-40.2%) | $1.59M(+261.3%) |
| Sep 2001 | - | $440.60K(-57.2%) |
| Jun 2001 | - | $1.03M(-60.1%) |
| Mar 2001 | - | $2.58M(-3.1%) |
| Dec 2000 | $2.66M(-23.9%) | $2.66M(+56.7%) |
| Sep 2000 | - | $1.70M(+5.9%) |
| Jun 2000 | - | $1.61M(-48.4%) |
| Mar 2000 | - | $3.11M(-11.0%) |
| Dec 1999 | $3.50M(-39.7%) | $3.50M(-5.4%) |
| Sep 1999 | - | $3.70M(-9.8%) |
| Jun 1999 | - | $4.10M(-18.0%) |
| Mar 1999 | - | $5.00M(-13.8%) |
| Dec 1998 | $5.80M(-31.8%) | $5.80M(-17.1%) |
| Sep 1998 | - | $7.00M(-15.7%) |
| Jun 1998 | - | $8.30M(+18.6%) |
| Mar 1998 | - | $7.00M(-17.6%) |
| Dec 1997 | $8.50M(+269.6%) | $8.50M(-14.1%) |
| Sep 1997 | - | $9.90M(+330.4%) |
| Jun 1997 | - | $2.30M(+64.3%) |
| Mar 1997 | - | $1.40M(-39.1%) |
| Dec 1996 | $2.30M | $2.30M(-28.1%) |
| Sep 1996 | - | $3.20M(+14.3%) |
| Jun 1996 | - | $2.80M |
FAQ
- What is TG Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for TG Therapeutics?
- What is TG Therapeutics annual cash & cash equivalents year-on-year change?
- What is TG Therapeutics quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for TG Therapeutics?
- What is TG Therapeutics quarterly cash & cash equivalents year-on-year change?
What is TG Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of TGTX is $179.89M
What is the all time high annual cash & cash equivalents for TG Therapeutics?
TG Therapeutics all-time high annual cash & cash equivalents is $553.44M
What is TG Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, TGTX annual cash & cash equivalents has changed by +$86.96M (+93.57%)
What is TG Therapeutics quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of TGTX is $132.14M
What is the all time high quarterly cash & cash equivalents for TG Therapeutics?
TG Therapeutics all-time high quarterly cash & cash equivalents is $553.44M
What is TG Therapeutics quarterly cash & cash equivalents year-on-year change?
Over the past year, TGTX quarterly cash & cash equivalents has changed by +$56.66M (+75.07%)